Mumbai, February 5, 2025 – Camlin Fine Sciences Limited has announced the appointment of Mr. Abeezar Faizullabhoy as an Additional Non-Executive Independent Director for a tenure of five years, effective February 4, 2025, subject to shareholder approval.
Key Details of the Appointment
- Board Approval: The Board of Directors, based on recommendations from the Nomination and Remuneration Committee, approved the appointment via Circular Resolution No. 2/2024-25 on February 4, 2025.
- Regulatory Compliance: The appointment aligns with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Profile of Abeezar Faizullabhoy
- Experience: With over 33 years in Dispute Resolution, Arbitration, and Corporate Commercial practice, Mr. Faizullabhoy brings extensive expertise in handling complex legal matters.
- Clientele: He has advised both domestic and international clients across diverse sectors such as manufacturing, technology, services, and retail.
- Legal Expertise:He specializes in:
- Arbitration & litigation, including matters before the Supreme Court, High Courts, and Tribunals.
- Insolvency and Bankruptcy Code (IBC) matters and enforcement of foreign decrees.
- Advisory on Joint Ventures, Angel/Private Equity Investments, Shareholder Agreements, and FDI regulations.
- Professional Journey: He began his career with Mulla & Mulla and Craigie, Blunt & Caroe, later working with JSA and HSA. Currently, he is a Senior Partner at Argus Partners (since 2019).
Additional Disclosures
- No Related Party Transactions: Mr. Faizullabhoy has no relation to any existing directors of the company.
- Regulatory Clearance: He is not debarred from holding a directorship by SEBI or any other regulatory authority.